Latest Sustainability News

Clover Corporation Limited has reported a robust financial year ending July 2025, with revenue climbing 38% and net profit soaring to $7 million. The company also announced a higher fully franked final dividend, reflecting its strengthened financial position.

SiteMinder's 2025 Investor Day presentation highlights its Smart Platform's progress, AI-driven hotel revenue tools, and reiterates a strong FY26 outlook with ambitions for accelerated growth.

Nuix Limited has showcased its strategic AI-driven growth plan centered on the Nuix Neo Platform and Deep Learning Framework, promising enhanced data processing and new regulatory solutions in FY26.

Australian Critical Minerals has completed its acquisition of Circuit Resources, securing a 25,600-hectare portfolio in Peru rich in precious and base metals, with multiple drill-ready projects poised for exploration.

Renergen Limited and Springbok Solar Power Plant have resolved a protracted legal dispute over land use rights, enabling both the Virginia Gas and Springbok Solar projects to operate collaboratively in South Africa's Free State.

INOVIQ Limited has demonstrated that its CAR-NK-exosome therapy kills over 90% of triple-negative breast cancer cells within 10 hours in laboratory tests, validating its potential as a next-generation cancer treatment.

Saunders International appoints Angelo De Angelis as CEO effective October 2025, succeeding Mark Benson who will support the transition through 2026. This leadership change signals a steady hand guiding the company’s next growth phase.

Savannah Goldfields is advancing steadily towards resuming gold production at its Georgetown plant, with environmental approvals secured and operational preparations underway for an October restart.

EBR Systems has secured final CMS approval for Transitional Pass-Through reimbursement for its WiSE CRT System, effective October 1, 2025, enhancing hospital adoption prospects in the U.S.

Environmental Clean Technologies Limited (ECT) has requested a voluntary suspension of its shares on the ASX as it prepares to announce a significant acquisition and capital raising.

ReNerve Limited has launched its Empliq tissue product range in the US, marking a strategic expansion into the growing dermal and amniotic tissue market. The launch complements its existing nerve repair portfolio and sets the stage for further growth.

Emyria secures a multi-year funding agreement with Medibank to support its Treatment-Resistant Depression program, marking a first for insurer-backed psychotherapy in Australia.